Document is current

Article History

Received: 20 December 2024

Accepted: 13 March 2025

First Online: 2 April 2025

Declarations

:

: This study was conducted in compliance with International Council on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use/Good Clinical Practice guidelines. Investigators received institutional review board, research ethics board, or independent ethics committee approval before the initiation of the study. All patients provided written informed consent.

: Not applicable.

: RRD is a consultant for Sumitomo Pharma America, Inc. ESR is a consultant for Sumitomo Pharma America, Inc., and Hologic and has received research funding from Allergan, Medtronic, and Uromedica. MJK is a consultant for AbbVie, Boston Scientific, Coloplast, Laborie, and Sumitomo Pharma America, Inc., and has received grant or research study funding from AbbVie, Axonics, Boston Scientific, Coloplast, and Cook Myosite. DKN is an editor at Digital Science Press; consultant for COSM, Convatec, and Sumitomo Pharma America, Inc.; and has received funding from Convatec and the National Institutes of Health. KX is an investigator for Sumitomo Pharma America, Inc., and is a consultant to and has received research funding from Medtronic. LA is an employee of Sumitomo Pharma America, Inc. ET and DS were employees of Sumitomo Pharma America, Inc., at the time the study was conducted.